← Back
Data updated: Jul 17, 2026
CONCORDIA PHARMS INC
Pharma Pharmaceuticals
CONCORDIA PHARMS INC is a pharmaceutical company with 3 FDA-approved products.
2000
Since
3
Drugs
-
Trials
0
New Drugs (2yr)
CONCORDIA PHARMS INC's Key Drugs
CONCORDIA PHARMS INC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
CONCORDIA PHARMS INC's Recent FDA Approvals
New NDA/BLA approvals for CONCORDIA PHARMS INC over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
CONCORDIA PHARMS INC's Therapeutic Areas
Disease areas where CONCORDIA PHARMS INC has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
CONCORDIA PHARMS INC Pipeline Snapshot
Active clinical trials for CONCORDIA PHARMS INC across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2000-12-14
- Latest
- 2020-02-06
- Applications
- 2